Douglas W. Lienesch

427 total citations
9 papers, 308 citations indexed

About

Douglas W. Lienesch is a scholar working on Rheumatology, Molecular Biology and Genetics. According to data from OpenAlex, Douglas W. Lienesch has authored 9 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 2 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Douglas W. Lienesch's work include Rheumatoid Arthritis Research and Therapies (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Hepatitis C virus research (2 papers). Douglas W. Lienesch is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Hepatitis C virus research (2 papers). Douglas W. Lienesch collaborates with scholars based in United States. Douglas W. Lienesch's co-authors include Jeremy S. Tilstra, Eswar Krishnan, C. Kent Kwoh, Mohamad Azhar, Vijay Saxena, Min Zhou, Thomas Doetschman, Ram Raj Singh, Ramireddy Bommireddy and Kenneth E. Sherman and has published in prestigious journals such as The Journal of Immunology, Lara D. Veeken and Lupus.

In The Last Decade

Douglas W. Lienesch

8 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas W. Lienesch United States 6 150 89 63 57 47 9 308
Byeongzu Ghang South Korea 12 148 1.0× 94 1.1× 71 1.1× 50 0.9× 38 0.8× 36 326
Syahrul Sazliyana Shaharir Malaysia 13 220 1.5× 59 0.7× 131 2.1× 25 0.4× 42 0.9× 38 327
Tina Mahajan United States 9 288 1.9× 68 0.8× 161 2.6× 40 0.7× 41 0.9× 11 430
Diana Castillo‐Martínez Mexico 11 125 0.8× 74 0.8× 63 1.0× 19 0.3× 30 0.6× 17 245
Desmond YH Yap Hong Kong 8 181 1.2× 108 1.2× 79 1.3× 33 0.6× 16 0.3× 13 262
Yong‐Wook Park South Korea 10 231 1.5× 71 0.8× 251 4.0× 28 0.5× 24 0.5× 13 445
L Allegri Italy 12 91 0.6× 252 2.8× 127 2.0× 54 0.9× 58 1.2× 24 441
Khalid Abulaban United States 9 184 1.2× 104 1.2× 114 1.8× 22 0.4× 16 0.3× 14 257
Julie Milojevic Switzerland 6 61 0.4× 102 1.1× 157 2.5× 23 0.4× 50 1.1× 9 359
Juan Javier Lichauco Philippines 8 284 1.9× 71 0.8× 171 2.7× 23 0.4× 13 0.3× 12 397

Countries citing papers authored by Douglas W. Lienesch

Since Specialization
Citations

This map shows the geographic impact of Douglas W. Lienesch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas W. Lienesch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas W. Lienesch more than expected).

Fields of papers citing papers by Douglas W. Lienesch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas W. Lienesch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas W. Lienesch. The network helps show where Douglas W. Lienesch may publish in the future.

Co-authorship network of co-authors of Douglas W. Lienesch

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas W. Lienesch. A scholar is included among the top collaborators of Douglas W. Lienesch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas W. Lienesch. Douglas W. Lienesch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Aggarwal, Rohit, et al.. (2018). Successful management of secondary cryofibrinogenaemia using bosentan therapy. Lara D. Veeken. 57(10). 1868–1870. 1 indexed citations
2.
Tilstra, Jeremy S. & Douglas W. Lienesch. (2015). Rheumatoid Nodules. Dermatologic Clinics. 33(3). 361–371. 64 indexed citations
3.
Saxena, Vijay, Douglas W. Lienesch, Min Zhou, et al.. (2008). Dual Roles of Immunoregulatory Cytokine TGF-β in the Pathogenesis of Autoimmunity-Mediated Organ Damage. The Journal of Immunology. 180(3). 1903–1912. 97 indexed citations
4.
Krishnan, Eswar, Douglas W. Lienesch, & C. Kent Kwoh. (2008). Gout in ambulatory care settings in the United States.. PubMed. 35(3). 498–501. 76 indexed citations
5.
Yeaney, Gabrielle, et al.. (2007). Neuromuscular Pathology Case. Journal of Clinical Neuromuscular Disease. 8(4). 234–236.
6.
Lienesch, Douglas W., et al.. (2006). Anti-Clq antibodies in patients with chronic hepatitis C infection.. PubMed. 24(2). 183–5. 16 indexed citations
7.
Lienesch, Douglas W., et al.. (2005). Absence of cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection.. PubMed. 32(3). 489–93. 33 indexed citations
8.
Albuquerque, Deijanira, Fanny M. Ebling, Douglas W. Lienesch, Ram Raj Singh, & Bevra H. Hahn. (2004). Analyses of serum levels of type 1, type 2 and type 3 cytokines reveal multiple abnormalities in lupus‐prone (NZB × NZW) F1 mice. APLAR Journal of Rheumatology. 7(1). 3–10. 3 indexed citations
9.
Lienesch, Douglas W., D F Mutasim, & Rupa Singh. (2003). Neutrophilic eccrine hidradenitis mimicking cutaneous vasculitis in a lupus patient: a complication of cyclophosphamide. Lupus. 12(9). 707–709. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026